Literature DB >> 34251604

15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic.

Carlo Garofalo1, Silvio Borrelli2, Toni De Stefano2, Luca De Nicola2, Carlo Vita2, Nicola Peruzzu2, Antonella Netti2, Giuseppe Conte2, Michele Provenzano3, Roberto Minutolo2.   

Abstract

PURPOSE: Changes over time of phenotype and prognosis in CKD patients starting nephrology care are undefined. This information is critical to correctly plan and optimize healthcare resources and clinical management in tertiary care.
METHODS: We performed a long-term observational cohort study including 2,866 non-dialysis CKD patients newly referred to our nephrology clinic from 2004 to 2018. Three cohorts were constituted based on 5-year calendar intervals (2004-2008, 2009-2013, and 2014-2018). The changes over time of main demographic, clinical and laboratory characteristics were compared among the three cohorts. We also compared between cohorts the risk of renal death (combined endpoint of renal replacement therapy-RRT, or death before RRT) as well as of the single components (RRT or death).
RESULTS: Across the three cohorts, we detected a significant increase in the prevalence of age ≥ 75 years (from 22.0 to 28.4%), male gender (from 53.1 to 62.1%), diabetes (from 32.6 to 39.5%), severe proteinuria ≥ 500 mg/24 h (from 46.9 to 52.4%). Mean eGFR at referral declined from 56.8 ± 27.0 to 49.6 ± 26.1 mL/min/1.73m2. Incidence of renal death significantly declined over time (5.36, 3.22 and 4.54/100 pts-year in 2004-2008, 2009-2013 and 2014-2018 cohorts, respectively). As compared with patients referred in 2004-2008, adjusted risk of renal death was lower in patients referred in 2009-2013 (HR 0.49, 95%CI 0.34-0.69) and 2014-2018 (HR 0.61, 95%CI 0.45-0.84). Similar results were obtained for RRT, while mortality did not change over time.
CONCLUSIONS: In the last 15 years, phenotype of newly referred CKD patients has remarkably changed with increasing frequency of older patients and more severe disease; however, renal survival improved suggesting greater efficacy of nephrology care.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  CKD; Nephrology care; Nephrology referral; Proteinuria/albuminuria; eGFR

Mesh:

Year:  2021        PMID: 34251604     DOI: 10.1007/s11255-021-02944-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings.

Authors:  Roberto Minutolo; Ferdinando C Sasso; Paolo Chiodini; Bruno Cianciaruso; Ornella Carbonara; Pasquale Zamboli; Giuseppina Tirino; Andrea Pota; Roberto Torella; Giuseppe Conte; Luca De Nicola
Journal:  J Hypertens       Date:  2006-08       Impact factor: 4.844

2.  Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016.

Authors:  Yan Xie; Benjamin Bowe; Ali H Mokdad; Hong Xian; Yan Yan; Tingting Li; Geetha Maddukuri; Cheng-You Tsai; Tasheia Floyd; Ziyad Al-Aly
Journal:  Kidney Int       Date:  2018-08-03       Impact factor: 10.612

3.  Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease.

Authors:  Chris Jones; Paul Roderick; Scott Harris; Mary Rogerson
Journal:  Nephrol Dial Transplant       Date:  2006-04-27       Impact factor: 5.992

4.  Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study.

Authors:  Ping Liu; Robert R Quinn; Mohammad Ehsanul Karim; Aminu Bello; Helen Tam-Tham; Robert Weaver; Paul E Ronksley; Hude Quan; Giovanni F M Strippoli; Braden Manns; Brenda R Hemmelgarn; Marcello Tonelli; Pietro Ravani
Journal:  CMAJ       Date:  2019-03-11       Impact factor: 8.262

5.  Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.

Authors:  Enrica Fung; Tara I Chang; Glenn M Chertow; I-Chun Thomas; Steven M Asch; Manjula Kurella Tamura
Journal:  Am J Kidney Dis       Date:  2017-08-12       Impact factor: 8.860

6.  Management of hypertension in patients with CKD: differences between primary and tertiary care settings.

Authors:  Roberto Minutolo; Luca De Nicola; Pasquale Zamboli; Paolo Chiodini; Giuseppe Signoriello; Clemente Toderico; Gennaro Arfè; Giuseppe Boschi; Ciro Brancati; Patrizia Iaccarino; Giuseppe Conte
Journal:  Am J Kidney Dis       Date:  2005-07       Impact factor: 8.860

7.  Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease.

Authors:  Chin-Lin Tseng; Elizabeth F O Kern; Donald R Miller; Anjali Tiwari; Miriam Maney; Mangala Rajan; Leonard Pogach
Journal:  Arch Intern Med       Date:  2008-01-14

8.  Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study.

Authors:  Roberto Minutolo; Francesco Lapi; Paolo Chiodini; Monica Simonetti; Elisa Bianchini; Serena Pecchioli; Iacopo Cricelli; Claudio Cricelli; Gaetano Piccinocchi; Giuseppe Conte; Luca De Nicola
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-29       Impact factor: 8.237

9.  Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of Chronic Kidney Diseases.

Authors:  Gerhard Lonnemann; Johannes Duttlinger; David Hohmann; Lennart Hickstein; Helmut Reichel
Journal:  Kidney Int Rep       Date:  2016-10-14

10.  Evaluating the feasibility of the KDIGO CKD referral recommendations.

Authors:  Karandeep Singh; Sushrut S Waikar; Lipika Samal
Journal:  BMC Nephrol       Date:  2017-07-07       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.